Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC)

World Journal of Urology

Volumn 30, Issue 5, 2012, Pages 693-700

  Neuhaus, Jochen ^a   Schulte Baukloh, Heinrich ^b   Stolzenburg, Jens Uwe ^a   Speroni di Fenizio, Pietro ^c   Horn, Lars Christian ^d   Rüffert, Henrik ^e   Hartenstein, Siegurd ^a   Burger, Maximilian ^f   Schulze, Matthias ^g   Schwalenberg, Thilo ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e HELIOS Hospital Borna   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

^g Urological Practice ^*  (Germany)

Author keywords

Confocal immunofluorescence; Detrusor smooth muscle cells; Histamine receptors; Interstitial cystitis; Muscarinic receptors; Purinergic receptors; Real time PCR

Indexed keywords

HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; TRANSCRIPTOME;

AGED; ARTICLE; BIOPSY; BLADDER; BLADDER TUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC SCREENING; GENETICS; HUMAN; INTERSTITIAL CYSTITIS; METABOLISM; METHODOLOGY; MIDDLE AGED; OVERACTIVE BLADDER; PAIN; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; SYNDROME;

AGED; BIOPSY; CYSTITIS, INTERSTITIAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TESTING; HUMANS; MIDDLE AGED; MUSCLE, SMOOTH; PAIN; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RECEPTORS, PURINERGIC P2X1; RECEPTORS, PURINERGIC P2X2; RECEPTORS, PURINERGIC P2X3; SYNDROME; TRANSCRIPTOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS; URINARY BLADDER, OVERACTIVE;

EID: 84868518447     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0774-0     Document Type: Article

References (28)

1. Abrams P, Cardozo L, Fall M et al (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61: 37-49.
2. Parsons JK, Parsons CL (2004) The historical origins of interstitial cystitis. J Urol 171: 20-22.
3. Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg LJ (1999) The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 161: 553-557.
4. van de Merwe JP, Nordling J, Bouchelouche P et al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53: 60-67.
5. Fall M, Baranowski AP, Elneil S et al (2010) EAU guidelines on chronic pelvic pain. Eur Urol 57: 35-48.
6. Parsons CL (2007) The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 69: 9-16.
7. Nazif O, Teichman JM, Gebhart GF (2007) Neural upregulation in interstitial cystitis. Urology 69: 24-33.
8. Erickson DR (2001) Urine markers of interstitial cystitis. Urology 57: 15-21.
9. Neuhaus J, Pfeiffer F, Wolburg H, Horn LC, Dorschner W (2005) Alterations in connexin expression in the bladder of patients with urge symptoms. BJU Int 96: 670-676.
10. Mukerji G, Yiangou Y, Grogono J et al (2006) Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 176: 367-373.
11. Pontari MA, Braverman AS, Ruggieri MRS (2004) The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction. Am J Physiol Regul Integr Comp Physiol 286: R874-R880.
12. Frazier EP, Peters SL, Braverman AS, Ruggieri MRS, Michel MC (2008) Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 377: 449-462.
13. Ford AP, Gever JR, Nunn PA et al (2006) Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol 147: S132-S143.
14. Yoshida M, Miyamae K, Iwashita H, Otani M, Inadome A (2004) Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63: 17-23.
15. Sun Y, Chai TC (2006) Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis. Am J Physiol Cell Physiol 290: C27-C34.
16. Sant GR, Kempuraj D, Marchand JE, Theoharides TC (2007) The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69: 34-40.
17. Neuhaus J, Oberbach A, Schwalenberg T, Stolzenburg JU (2006) Cultured smooth muscle cells of the human vesical sphincter are more sensitive to histamine than are detrusor smooth muscle cells. Urology 67: 1086-1092.
18. Bouchelouche K, Bouchelouche P (2006) Cysteinyl leukotriene d(4) increases human detrusor muscle responsiveness to histamine. J Urol 176: 361-366.
19. Thilagarajah R, Witherow RO, Walker MM (2001) Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int 87: 207-212.
20. Theoharides TC, Sant GR (1997) Hydroxyzine therapy for interstitial cystitis. Urology 49: 108-110.
21. Hanno PM, Burks DA, Clemens JQ et al (2011) AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 185: 2162-2170.
22. Rasband WS ImageJ. US National Institutes of Health, Bethesda, Maryland, USA, http://rsb. info. nih. gov/ij/, 1997-2006.
23. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
24. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467.
25. Varambally S, Yu J, Laxman B et al (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8: 393-406.
26. Mansfield KJ, Liu L, Moore KH, Vaux KJ, Millard RJ, Burcher E (2007) Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity. BJU Int 99: 1433-1438.
27. Ruggieri MRS, Braverman AS (2006) Regulation of bladder muscarinic receptor subtypes by experimental pathologies. Auton Autacoid Pharmacol 26: 311-325.
28. Braverman AS, Tibb AS, Ruggieri MRS (2006) M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. I. Normal rat bladder. J Pharmacol Exp Ther 316: 869-874.